Adenosine A2a receptors increase arterial endothelial cell nitric oxide

Area of Science:

• Cardiovascular Physiology
• Endothelial Cell Biology
• Pharmacology

Background:

• Adenosine is a known vasodilator of vascular smooth muscle.
• Endothelium-derived nitric oxide (NO) also mediates vasodilation.
• Previous studies indicated adenosine stimulates NO production in porcine cells via receptor mechanisms.

Purpose of the Study:

• To investigate if adenosine enhances NO production in human arterial endothelium.
• To determine the specific roles of adenosine A1 and A2 receptors in this process.

Main Methods:

• Human iliac arterial endothelial cells (HIAEC) and porcine carotid arterial endothelial cells (PCAEC) were cultured.
• Real-time NO production was continuously measured using a NO electrode sensor.
• Various adenosine receptor agonists and antagonists were employed to assess receptor involvement.

Main Results:

• Adenosine significantly increased NO production in both HIAEC and PCAEC.
• Selective adenosine A2a receptor agonists (e.g., CGS-21680) enhanced NO production.
• Selective adenosine A1 receptor agonists (e.g., CCPA) significantly decreased NO production, an effect blocked by A1 antagonists.

Conclusions:

• Adenosine A2a receptors positively regulate NO production in human and porcine arterial endothelial cells.
• Adenosine A1 receptors negatively regulate NO production in these cells.
• These findings elucidate the differential roles of adenosine receptor subtypes in endothelial NO synthesis.